Who are Arsenal Medical's investors?

Arsenal Medical's investors include North Bridge Venture Partners.

How much funding has Arsenal Medical raised?

Arsenal Medical has disclosed $6M raised across 1 round.

Where is Arsenal Medical headquartered?

Arsenal Medical is headquartered in Watertown, US.

Arsenal Medical

Watertown, US · Delaware corporation · 29 employees on LinkedIn · 1 known investors

Find your way into Arsenal Medical

445 people in our graph share verified history with the Arsenal Medical team — schools, employers, funds. One of them is your warm intro.

Brian Dixonunlockedknows Carol Pekar · together at Northeastern University (overlapped)

×6knows the team · via Babson F.W. Olin Graduate School of Business

×2knows the team · via Worcester Polytechnic Institute

knows the team · via Boston University School of Medicine

knows the team · via Material Impact

knows the team · via St. Bonaventure University

Arsenal Medical develops a platform of biomaterials for medical applications, including ResQFoam for hemorrhage control and NeoCast, advancing products through clinical trials and FDA regulatory pathways. The company focuses on biomaterial-based medical devices and combination products across clinical indications.

Biotech Medical Devices New Materials

Founders & leadership

Upma Sharma inPresident & CEOMedical, Biomaterials President, Arsenal Medicine at Material Impact

Alan Kilyk inChief Financial OfficerAlan Kilyk is Chief Financial Officer of Arsenal Medical, a biomaterial platform company developing medical devices for hemorrhage control and other clinical applications. He brings over 20 years of finance leadership experience, including work on mergers and acquisitions, regulatory compliance, and financial operations at public companies.

Lee Core inChief Operating OfficerHe brings over 25 years of medical device development experience, including bringing multiple product lines through clinical and commercial stages, with expertise spanning product development, manufacturing, quality assurance, regulatory affairs, and business development across implantable devices, disposables, and combination products.

Carol Pekar inExecutive Vice President, Clinical and RegulatoryCarol Pekar holds an MBA from Babson and certificates in clinical research and regulatory affairs from Boston University School of Medicine and Northeastern University, respectively. She brings extensive experience in clinical trial management and FDA regulatory pathways across drugs, biologics, medical devices, and combination products, including 505(b)(2) NDAs, PMAs, HDEs, and 510(k)s, along with expertise in CE marking and international product approvals.

Richard W MottNamed on SEC filing

Thomas A FitzgeraldNamed on SEC filing

Robert LangerCo-founder

George WhitesidesCo-founder

Board

Dennis DoughertyBoard directorManaging General Partner at Intersouth Partners

Terrance McGuireBoard director

Carmichael RobertsCo-founderGeneral Partner at North Bridge Venture Partners

Investors · 1

North Bridge Venture PartnersreportedWaltham

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 1 round · 2019

▶$6MraisedJun 2019 · 12 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Richard W MottDirector
Dennis DoughertyDirector
Thomas A FitzgeraldExecutive Officer
Robert LangerDirector
Terrance McGuireDirector
Carmichael RobertsDirector
George WhitesidesDirector
Upma SharmaExecutive Officer

Offering amount: $6M
Amount sold: $6M
First sale: May 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

medcura17 shared keywordsMedcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion. Its offerings target surgeons, patients, and payers in the surgical hemostasis market, including specialized applications such as spine surgery.

Companies competing with Arsenal Medical for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Arsenal Medical, Led by Upma Sharma, Raises $6 Million - INDIA New England Newsindianewengland.com · Jun 2019

Arsenal Medical Secures Funding From US Army To Advance Resqfoam Trauma Product Through Regulatory Approval - BioSpacebiospace.com · Dec 2015

Arsenal Medical Spun Out 480 Biomedical; Both Completes Financings - FinSMEsfinsmes.com · Oct 2011

Frequently asked questions

What does Arsenal Medical do?: Arsenal Medical develops a platform of biomaterials for medical applications, including ResQFoam for hemorrhage control and NeoCast, advancing products through clinical trials and FDA regulatory pathways. The company focuses on biomaterial-based medical devices and combination products across clinical indications.
Who are Arsenal Medical's investors?: Arsenal Medical's investors include North Bridge Venture Partners.
How much funding has Arsenal Medical raised?: Arsenal Medical has disclosed $6M raised across 1 round.
Where is Arsenal Medical headquartered?: Arsenal Medical is headquartered in Watertown, US.